Regulatory Genome

Cambridge, United Kingdom

Regulatory Genome provides machine-readable regulatory content to increase accessibility and dissemination of information.

$6.0M raised

Apr 2022

Seed

Artificial Intelligence (AI)Machine Learning Text Analytics

Top Investors

Mastercard Evolution Equity Partners AlbionVC University of Cambridge Enterprise

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Regulatory Genome

How much funding has Regulatory Genome raised?

Regulatory Genome has raised $6.0M in total funding. The most recent round was Seed. The last funding was announced in April 2022.

Who are Regulatory Genome's investors?

Regulatory Genome's investors include Mastercard, Evolution Equity Partners, AlbionVC, University of Cambridge Enterprise.

Where is Regulatory Genome headquartered?

Regulatory Genome is headquartered in Cambridge, United Kingdom.

What does Regulatory Genome do?

Regulatory Genome provides machine-readable regulatory content to increase accessibility and dissemination of information.

What stage is Regulatory Genome at?

Regulatory Genome is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 11, 2022.

MLA

"Regulatory Genome — Funding & Investors." VCBacked, April 11, 2022, https://www.vcbacked.co/company/regulatory-genome. Accessed July 2, 2026.

APA

VCBacked. (2022). Regulatory Genome — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/regulatory-genome

Wikipedia (cite web)

{{cite web |title=Regulatory Genome — Funding & Investors |url=https://www.vcbacked.co/company/regulatory-genome |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 11, 2022.

Similar Companies in Artificial Intelligence (AI)

Fort Lauderdale$50.0M